Effect of Anti-IgE in Non-Allergic Asthma

Trial Profile

Effect of Anti-IgE in Non-Allergic Asthma

Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Asthma
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Mar 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology
    • 27 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top